Search research articles
Contact Us
Filters
Showing results (281-290 of 481) with videos related to
Page
of 49
Sort By:
European Journal of Preventive Cardiology
|
December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
Ella Zomer, Si Si, Thomas R Hird, et al.
Pharmacoeconomics
|
March 22, 2023
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031
Dina Abushanab, Clara Marquina, Jedidiah I Morton, et al.
Open Heart
|
May 8, 2021
Impact of emergency medical service delays on time to reperfusion and mortality in STEMI
Ahmad Alrawashdeh, Ziad Nehme, Brett Williams, et al.
Clinical Cardiology
|
February 22, 2022
The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data
Peter Lee, Angela Brennan, Diem Dinh, et al.
World Journal of Methodology
|
February 2, 2019
Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?
Pupalan Iyngkaran, William Chan, Danny Liew, et al.
Journal of Clinical Lipidology
|
September 15, 2020
The economic impact of familial hypercholesterolemia on productivity
Zanfina Ademi, Clara Marquina, Ella Zomer, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 8, 2018
The role of dihydrosphingolipids in disease
Ruth R Magaye, Feby Savira, Yue Hua, et al.
BMJ Open
|
December 8, 2021
Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study
Peter Lee, Angela L Brennan, Dion Stub, et al.
Heart, Lung & Circulation
|
January 16, 2022
Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis
Jennifer Y Zhou, Emilia Nan Tie, Danny Liew, et al.
Diabetes Care
|
July 1, 2022
The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
Anthony Pease, Emily Callander, Ella Zomer, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 481) with videos related to
Sort By:
Page
of 49
European Journal of Preventive Cardiology
|
December 12, 2018
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
Ella Zomer, Si Si, Thomas R Hird, et al.
Pharmacoeconomics
|
March 22, 2023
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022-2031
Dina Abushanab, Clara Marquina, Jedidiah I Morton, et al.
Open Heart
|
May 8, 2021
Impact of emergency medical service delays on time to reperfusion and mortality in STEMI
Ahmad Alrawashdeh, Ziad Nehme, Brett Williams, et al.
Clinical Cardiology
|
February 22, 2022
The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data
Peter Lee, Angela Brennan, Diem Dinh, et al.
World Journal of Methodology
|
February 2, 2019
Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?
Pupalan Iyngkaran, William Chan, Danny Liew, et al.
Journal of Clinical Lipidology
|
September 15, 2020
The economic impact of familial hypercholesterolemia on productivity
Zanfina Ademi, Clara Marquina, Ella Zomer, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 8, 2018
The role of dihydrosphingolipids in disease
Ruth R Magaye, Feby Savira, Yue Hua, et al.
BMJ Open
|
December 8, 2021
Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study
Peter Lee, Angela L Brennan, Dion Stub, et al.
Heart, Lung & Circulation
|
January 16, 2022
Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis
Jennifer Y Zhou, Emilia Nan Tie, Danny Liew, et al.
Diabetes Care
|
July 1, 2022
The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
Anthony Pease, Emily Callander, Ella Zomer, et al.
Page
of 49